For instance, in 2019, in India, as per the Neurology India’s data, the common neurological disorders are stroke with 37.9%, followed by headache disorder with 17.5%, epilepsy with 11.3% and cerebral palsy with 5.7%.
The Asia Pacific neurostimulation devices market is segmented into device type, application, company, and country. Based on device type, the market is categorized into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Out of which, the spinal cord stimulators segment dominated the market in 2022 and is expected to maintain its dominance during the forecast period. This is attributed to high growth in number of product approvals, and rising demand for treating neuropathic pain and spinal injuries. Based on country, China is expected to dominate the market during the forecast period. This is due to surge in research and development activity, and use of integrated internal neurostimulation device in proteomic, genomic and clinical diagnostics, coupled with the growing demand for advanced neurostimulation devices in the treatment of chronic pain management.
Major players operating in the Asia Pacific neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc. and others. The key market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements in order to expand their geographic reach and to increase their customer bases.
Objective of the Study
- To analyze and estimate the market size of Asia Pacific neurostimulationdevices market from 2018 to 2021.
- To estimate and forecast the market size of Asia Pacific neurostimulationdevices market from 2022 to 2028 and growth rate until 2028.
- To classify and forecast Asia Pacific neurostimulation devices marketbased on device type, application, company and country-wise distribution.
- To identify dominant region or segment in the Asia Pacific neurostimulationdevices market.
- To identify drivers and challenges for Asia Pacific neurostimulationdevices market.
- To examine competitive developments such as expansions, new productlaunches, mergers & acquisitions, etc., in Asia Pacific neurostimulationdevices market.
- To conduct pricing analysis for Asia Pacific neurostimulation devicesmarket.
- To identify and analyze the profile of leading players operating in AsiaPacific neurostimulation devices market.
- To identify key sustainable strategies adopted by market players in AsiaPacific neurostimulation devices market.
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of manufacturers across the region. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers which could not be identified due to the limitations of secondary research. Market insights research analyzed the manufacturers and presence of all major players across the region.
Market insights research calculated the market size of
Key Target Audience
- Neurostimulationdevices manufacturers, suppliers and other stakeholders.
- Government bodiessuch as regulating authorities and policy makers.
- Organizations,forums and alliances related to neurostimulation devices.
- Market researchand consulting firms.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, Volume forecast, Company share, Competitive landscape, Growth factors, and Trends |
| Segments covered | Device Type Application Country |
| Country scope | China, India, Japan, South Korea, Singapore, Australia, Malaysia, Thailand, Vietnam, Indonesia |
| Key companies profiled | Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc, NeuroSigma, Inc., Synapse Biomedical Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
